
GLP-2 Receptor Agonist Analog
MISSION CRITICAL: For in vitro laboratory research only. Not for human or veterinary use. Not evaluated by the FDA. Must be 21+.
GLP-2(T) is a teduglutide-class GLP-2 receptor agonist research peptide with the molecular formula C₂₂₅H₃₄₈N₄₈O₆₈ and a molecular weight of 4813.53 g/mol (CAS: 2023788-19-2), a GLP-2 analog resistant to dipeptidyl peptidase-4 (DPP-4) cleavage, studied in intestinal epithelial cell models for GLP-2 receptor signal transduction. Supplied at ≥99% HPLC purity as a lyophilized powder for in vitro research use only.
GLP-2(T) binds GLP-2R and triggers adenylyl cyclase-mediated cAMP elevation in intestinal crypt and villus cell models (PMID: 22189863).
N-terminal glycine substitution confers resistance to DPP-4 enzymatic cleavage, extending biological activity in proteolytic stability assays (PMID: 19826478).
Drucker et al. (2011) examined GLP-2 receptor distribution and downstream cAMP signaling in intestinal cell culture models (PMID: 22189863).
Drucker DJ, et al. (2011). Gut hormones: GLP-2 receptor biology and intestinal physiology. J Clin Invest.PMID: 19826478Jeppesen et al. (2009) analyzed GLP-2R agonist-mediated effects on intestinal mucosal architecture in cell and tissue models (PMID: 19826478).
Jeppesen PB, et al. (2009). Teduglutide reduces the need for parenteral support in patients with short bowel syndrome. Gut.